Back to Search
MONA JAGGI, M.D.
M.D.
Emergency Medicine Physician
NPI: 1912004508Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
25MA06891300(NJ)
Research & Publications (20)
Evaluation of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agents.
PMID 19424664·Invest New Drugs·2010
7-preclinical
Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
PMID 18720190·J Enzyme Inhib Med Chem·2009
8-other
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.
PMID 19647803·Drug Discov Today·2009
6-review
Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
PMID 19555167·J Enzyme Inhib Med Chem·2009
8-other
Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin.
PMID 19141652·Cancer Res·2009
7-preclinical
Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
PMID 19176398·Cancer Res·2009
7-preclinical
Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
PMID 19135530·Eur J Pharm Sci·2009
7-preclinical
Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
PMID 18316139·Eur J Med Chem·2009
8-other
Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
PMID 19470292·J Pharm Pharm Sci·2009
8-other
Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa.
PMID 19109793·Methods Mol Biol·2009
8-other
1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
PMID 19361894·Eur J Med Chem·2009
7-preclinical
A compactly fused pi-conjugated tetrathiafulvalene-perylenediimide donor-acceptor dyad.
PMID 19537773·Org Lett·2009
8-other
Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
PMID 18619980·Life Sci·2008
7-preclinical
Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
PMID 18752941·Bioorg Med Chem Lett·2008
8-other
Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
PMID 18761148·Talanta·2008
4-observational
Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptors.
PMID 18217205·Invest New Drugs·2008
7-preclinical
DNA-encoded chemical libraries for the discovery of MMP-3 inhibitors.
PMID 18254582·Bioconjug Chem·2008
8-other
Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas.
PMID 18322652·Invest New Drugs·2008
8-other
Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells.
PMID 18602367·Biochem Biophys Res Commun·2008
8-other
Bryostatin 1 modulates beta-catenin subcellular localization and transcription activity through protein kinase D1 activation.
PMID 18765827·Mol Cancer Ther·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 355 GRAND ST, DEPARTMENT OF EMERGENCY MEDICINE
JERSEY CITY, NJ 07302 - Phone
- (201) 915-2218
Quick Facts
- NPI
- 1912004508
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile